6533b824fe1ef96bd1280083

RESEARCH PRODUCT

jop-2017-3257-File005 – Supplemental material for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis

Patricia GassóSergi MasMiquel BioqueBibiana CabreraAntonio LoboAna González-pintoCovadonga M. Díaz-canejaIluminada CorripioEduard VietaJosefina Castro-fornielesSalvador SarróAnna ManéJulio SanjuanAdrián LlerenaAmalia LafuenteJerónimo Saiz-ruizMiguel Bernardo

subject

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified110904 Neurology and Neuromuscular Diseases

description

Supplemental material, jop-2017-3257-File005 for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis by Patricia Gassó, Sergi Mas, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M. Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Salvador Sarró, Anna Mané, Julio Sanjuan, Adrián Llerena, Amalia Lafuente, Jerónimo Saiz-Ruiz, Miguel Bernardo and PEPs Group in Journal of Psychopharmacology

https://dx.doi.org/10.25384/sage.6480479.v1